Monroe Carell Jr. Children's Hospital at Vanderbilt, also known as Children's Hospital at Vanderbilt, is a nationally ranked pediatric acute care children's teaching hospital and entity of Vanderbilt University Medical Center in Nashville, Tennessee.

There are 343 beds in Vanderbilt Children's Hospital.

During the past decade, Vanderbilt Children's Hospital conducted 68 clinical trials. In the 10-year time frame, 68 clinical trials started and 46 clinical trials were completed, i.e. on average, 67.6% percent of trials that started reached the finish line to date. In the past 5 years, 27 clinical trials started and 27 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Vanderbilt Children's Hospital" #1 sponsor was "Vanderbilt University Medical Center" with 26 trials, followed by "Vanderbilt University" with 12 trials sponsored, "Children's Oncology Group" with 11 trials sponsored, "Therapeutic Advances in Childhood Leukemia Consortium" with 7 trials sponsored and "Gilead Sciences" with 7 trials sponsored. Other sponsors include 98 different institutions and companies that sponsored additional 84 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Vanderbilt Children's Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 13 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 8 trials as a collaborator, "National Institutes of Health (NIH)" with 8 trials as a collaborator, "Children's Hospital Medical Center, Cincinnati" with 6 trials as a collaborator and "Washington University School of Medicine" with 6 trials as a collaborator. Other collaborators include 214 different institutions and companies that were collaborators in the rest 141 trials.

According to Clinical.Site data, the most researched conditions in "Vanderbilt Children's Hospital" are "Cystic Fibrosis" (6 trials), "Neuroblastoma" (6 trials), "Leukemia" (5 trials), "Bronchopulmonary Dysplasia" (4 trials) and "Pain" (4 trials). Many other conditions were trialed in "Vanderbilt Children's Hospital" in a lesser frequency.

Most popular intervention types in "Vanderbilt Children's Hospital" are "Drug" (84 trials), "Other" (20 trials), "Biological" (13 trials), "Device" (13 trials) and "Procedure" (13 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "cyclophosphamide" (6 trials), "radiation therapy" (6 trials), "filgrastim" (5 trials) and "doxorubicin hydrochloride" (4 trials). Other intervention names were less common.

The vast majority of trials in "Vanderbilt Children's Hospital" are 158 trials for "All" genders, 5 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are 44 active trials in "Vanderbilt Children's Hospital". 2 are not yet recruiting, 28 are recruiting, 13 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 95 completed trials in Vanderbilt Children's Hospital, undefined suspended trials, and 12 terminated clinical trials to date.

Out of the total trials that were conducted in Vanderbilt Children's Hospital, 22 "Phase 1" clinical trials were conducted, 30 "Phase 2" clinical trials and 31 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 9 trials, and there were also 32 trials that are defined as “Not Applicable".

Vanderbilt Children's Hospital has several departments that took part in Clinical trials: "Vanderbilt Pediatric Primary Care Clinic" - 4 trials, "Vanderbilt Children's Orthopaedics" - 2 trials